Drug Type Small molecule drug |
Synonyms Y3, OW 30, OW-30 + [6] |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists), PSD95 inhibitors(Disks large homolog 4 inhibitors), nNOS inhibitors(Nitric-oxide synthase, brain inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 3 | CN | 24 Jul 2024 | |
Depressive Disorder | Phase 3 | CN | - | |
Ischemic stroke | Preclinical | US | 01 Dec 2024 |